Market leadership Position QC Kinetix as a leading non-surgical regenerative medicine provider with rapid growth, recent national conference activity, and recognition from Inc. 5000 and Franchise Times to open doors with potential franchisees and medical partners seeking scalable, innovative pain relief solutions.

Franchise growth Leverage its fast-growing franchise model and national reach to identify B2B opportunities with clinics, hospitals, and medical distributors seeking to expand ancillary pain management services without invasive surgeries.

Medical leadership Target partnerships and speaking engagements with high-profile medical directors and orthopedic specialists (e.g., National Medical Director) to create referral networks, co-branded clinical programs, and physician credentialing deals.

Regenerative tech Promote adoption of regenerative medicine technologies and orthobiologic care as a non-surgical alternative, offering partnerships with equipment suppliers, training organizations, and payer-aligned programs to expand treatment adoption.

Reputation risk Address potential reputational and regulatory concerns highlighted by recent litigation news by offering transparent patient education, compliant sales practices, and third-party patient outcome data to reassure stakeholders and preserve trust.